Skip to main content
. 2017 Apr 4;13:18. doi: 10.1186/s13223-017-0183-z

Fig. 4.

Fig. 4

Changes from baseline in total and individual item scores of the RQLQ after 2 weeks of randomized therapy. a Phase 2 trial (based on modified all-treated set) and b Phase 3 trial based on modified ITT (intent-to-treat) set. All data are expressed as mean (95% CI). RQLQ rhinoconjunctivitis quality-of-life questionnaire. *p < 0.05 for change from baseline with setipiprant vs. placebo; p < 0.05 for change from baseline with cetirizine vs. placebo